Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal Czech Filtered by asset OPCH

Coverage 170,674 Raw stories ingested 22,591 rewritten in CS_CZ • 2 to rewrite (last 2 days).

Symbols 2,794 Assets with fetched stories

Cryptocurrencies BTC 7,507 ETH 4,952 XRP 3,373 SOL 3,057 HYPE 1,800 USDC 1,629

Stocks NVDA 1,842 SPCX 1,475 MU 1,364 MSFT 1,325 AAPL 1,143 AMZN 1,069

Commodities GOLD 563 SILVER 301 OIL 106 PLATINUM 14 PALLADIUM 4 COPPER 3

Forex EURUSD 511 GBPUSD 388 USDCAD 156 USDJPY 151 AUDUSD 100 EURJPY 63

2,200 with rewritten stories in CS_CZ • Hot assets ranked by fetched stories.

Agents 7 Live Pipeline agents

FMP Stock News Fetch every minute 20s ago
FMP Forex News Fetch every 5 min 4m ago
CoinGecko News Fetch every 5 min 1m ago
FIO Stock News Fetch every 10 min 5m ago
Patria Stock News Fetch every 10 min 5m ago
Editorial rewrite Rewrite every minute running now
Asset sync Assets every 1 hour 34m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

Category Source Ticker

Relevance

Clear

Details	Date	Content	Source	Relevance
	Saved 2026-08-05 11:41 1mo ago Published 2026-08-05 03:09 1mo ago	Amundi snížila podíl v Option Care Health o 5,1 % Amundi v 1. čtvrtletí snížila podíl v Option Care Health o 5,1 % a prodala 38 525 akcií. Po obchodu držela 709 607 akcií v hodnotě 19,103 mil. USD. OPCH Option Care Health	FMP Stock News	72
Original source text Posted by Defense World Staff on Aug 5th, 2026 Amundi reduced its holdings in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 5.1% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 709,607 shares of the company’s stock after selling 38,525 shares during the quarter. Amundi owned 0.45% of Option Care Health worth $19,103,000 at the end of the most recent reporting period. Several other institutional investors and hedge funds have also modified their holdings of OPCH. Durable Capital Partners LP boosted its stake in Option Care Health by 134.2% in the 2nd quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after purchasing an additional 4,720,988 shares during the period. Fuller & Thaler Asset Management Inc. grew its holdings in shares of Option Care Health by 12.1% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 6,958,800 shares of the company’s stock worth $221,707,000 after buying an additional 752,058 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its position in Option Care Health by 6.2% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 4,248,425 shares of the company’s stock valued at $135,355,000 after buying an additional 247,118 shares during the last quarter. Dimensional Fund Advisors LP raised its position in Option Care Health by 0.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,876,856 shares of the company’s stock valued at $104,368,000 after buying an additional 36,208 shares during the last quarter. Finally, Southpoint Capital Advisors LP lifted its stake in Option Care Health by 20.0% in the 1st quarter. Southpoint Capital Advisors LP now owns 3,600,000 shares of the company’s stock valued at $96,912,000 after acquiring an additional 600,000 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds. Insider Transactions at Option Care Health In other news, Director Timothy P. Sullivan bought 24,154 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The stock was acquired at an average cost of $20.69 per share, for a total transaction of $499,746.26. Following the purchase, the director owned 73,383 shares of the company’s stock, valued at approximately $1,518,294.27. This trade represents a 49.06% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 1.70% of the company’s stock. Wall Street Analyst Weigh In A number of research firms have weighed in on OPCH. Stephens reaffirmed an “equal weight” rating and set a $24.00 price target (down from $30.00) on shares of Option Care Health in a research report on Friday, July 17th. Barrington Research cut their price objective on shares of Option Care Health from $42.00 to $32.00 and set an “outperform” rating on the stock in a research report on Friday, May 1st. UBS Group restated a “buy” rating on shares of Option Care Health in a report on Tuesday, June 16th. Wall Street Zen raised shares of Option Care Health from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, TD Cowen cut their price target on shares of Option Care Health from $37.00 to $23.00 and set a “hold” rating on the stock in a research report on Friday, May 1st. Seven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $29.92. Check Out Our Latest Research Report on OPCH Option Care Health Price Performance NASDAQ:OPCH opened at $23.69 on Wednesday. The stock has a market capitalization of $3.55 billion, a PE ratio of 17.81, a P/E/G ratio of 1.41 and a beta of 0.65. Option Care Health, Inc. has a 1-year low of $18.01 and a 1-year high of $36.80. The firm has a fifty day simple moving average of $21.59 and a 200 day simple moving average of $26.60. The company has a current ratio of 1.47, a quick ratio of 0.98 and a debt-to-equity ratio of 0.91. Option Care Health (NASDAQ:OPCH – Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.02. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. The firm had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.42 billion. During the same period in the prior year, the firm posted $0.41 earnings per share. The company’s quarterly revenue was up 1.9% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. On average, research analysts expect that Option Care Health, Inc. will post 1.64 EPS for the current fiscal year. Option Care Health Company Profile (Free Report) Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting. Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses. Featured Articles Five stocks we like better than Option Care Health System Upgrade: First Internet Bancorp Options Surge AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push The AI Chip Blockade Is Creating a Shadow Market Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Free Report). Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter. « PREVIOUS HEADLINEVirtual Reality Stocks To Consider – August 3rd NEXT HEADLINE »Top Small Cap Stocks To Watch Now – August 3rd
	Saved 2026-07-29 15:10 1mo ago Published 2026-07-29 09:31 1mo ago	Option Care překonala odhady zisku na akcii i tržeb ve 2. čtvrtletí Option Care (OPCH) ve 2. čtvrtletí vykázala zisk 0,45 USD na akcii a tržby 1,44 mld. USD, obojí nad odhady trhu. OPCH Option Care Health	FMP Stock News	78
Original source text Option Care (OPCH - Free Report) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.41 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +7.14%. A quarter ago, it was expected that this infusion and home care services company would post earnings of $0.37 per share when it actually produced earnings of $0.4, delivering a surprise of +8.11%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Option Care, which belongs to the Zacks Medical - Outpatient and Home Healthcare industry, posted revenues of $1.44 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 1.68%. This compares to year-ago revenues of $1.42 billion. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Option Care shares have lost about 29.4% since the beginning of the year versus the S&P 500's gain of 8.5%. What's Next for Option Care?While Option Care has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Option Care was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.48 on $1.45 billion in revenues for the coming quarter and $1.83 on $5.71 billion in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Outpatient and Home Healthcare is currently in the top 35% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. One other stock from the same industry, U.S. Physical Therapy (USPH - Free Report) , is yet to report results for the quarter ended June 2026. The results are expected to be released on August 5. This physician staffing services company is expected to post quarterly earnings of $0.85 per share in its upcoming report, which represents a year-over-year change of +4.9%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. U.S. Physical Therapy's revenues are expected to be $213.4 million, up 8.1% from the year-ago quarter.